Pharmaceutical composition of nanoparticles

Details Pharmaceutical composition of nanoparticles Pharmaceutical composition of nanoparticles

2011-08-09

2011-08-09

Monshipouri, Maryam (Department: 1656)

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

C424S001730

Reexamination Certificate

active

07993625

ABSTRACT:
The invention discloses a pharmaceutical composition of bioactive nanoparticles composed of chitosan, poly-glutamic acid, and a pegylated bioactive agent for oral delivery. The chitosan-based nanoparticles are characterized with a positive surface charge and enhanced permeability for oral drug delivery.

REFERENCES:
patent: 6383478 (2002-05-01), Prokop et al.
patent: 6649192 (2003-11-01), Alonso Fernandez et al.
patent: 2006/0051423 (2006-03-01), Heppe et al.
van der Lubben IM et al. “Chitosan and its derivatives in mucosal drug and vaccine delivery” Euro J Pharma Sci 2001;14:201-207.
Hosny EA et al. “Oral delivery of insulin from enteric-coated capsules containing sodium salicylate” Int J Pharmaceutics 2002;237:71-76.
Thanou M et al. “Chitosan and its derivatives as intestinal absorption enhancers” Adv. Drug Deliv. Rev. 2001;50:S91-S101.
Smith J et al. “Effect of chitosan on epithelial cell tight junctions” Pharmaceutical Research 2004;21:43-49.

Affiliated with

Also associated with

Rating

Pharmaceutical composition of nanoparticles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition of nanoparticles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition of nanoparticles will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2715102